Good levels to buy TRVN

2020년 11월 17일

Very bullish for NASDAQ:TRVN in the long term.
- High demand product with blockbuster drug good for opiod crisis.
- Potential replacement for morphine, no real competitor
- Partnership with Syneos for sales
- Potential buyout

Good levels to buy at 2.50 and 2.33

Should see rise towards next quarter earnings.

Long term PTs
TP1 - $5
TP2 - $15
TP3 - $30

2020년 12월 8일

노트

hold

2020년 12월 27일

노트

Falling wedge pattern in the short term and an ascending triangle on the mid term.

Continue hold towards next quarter earnings in March

2021년 1월 6일

액티브 트레이드

finance.yahoo.com/news/trevena-inc-provides-commercial-launch-120000483.html

2021년 1월 7일

노트

Seems to breaking out of the falling wedge